Skip to main content
OpenTrials

Clinical trial condition

Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer

Explore clinical trials studying Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer trial results

Completed

Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study

NCT03891238

Conditions
Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Istituto Tumori "Giovanni Paolo II" IRCCS Ospedale Oncologico di Bari Bari, Italy
  • ASST Papa Giovanni XXIII Bergamo, Italy
  • Ospedale Santa Croce - A.O. Ospedali Riuniti Marche Nord Fano, Italy
  • IRCCS Ospedale Policlinico San Martino Genova, Italy
View all 21 locations
View Trial Details

Related conditions